New drug hope for fatty liver in PCOS women?

NCT ID NCT03617263

Terminated Disease control Sponsor: Zydus Therapeutics Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a drug called saroglitazar in women with polycystic ovary syndrome (PCOS) who also have nonalcoholic fatty liver disease (NAFLD). The goal was to see if the drug could safely reduce liver fat over 24 weeks compared to a placebo. The trial was planned for 60 women aged 18 to 45, but it was terminated early.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON-ALCOHOLIC FATTY LIVER DISEASE IN WOMEN WITH PCOS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

metabolic dysfunction-associated steatotic liver disease polycystic ovary syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

NON-ALCOHOLIC FATTY LIVER DISEASE IN WOMEN WITH PCOS

Contacts and locations

Locations

Zydus MX001

Monterrey, Nuevo León, 64460, Mexico
Zydus MX002

Monterrey, Nuevo León, 64460, Mexico
Zydus MX003

Mexico City, 06100, Mexico
Zydus MX004

Mérida, Yucatán, 97070, Mexico
Zydus MX005

Culiacán, Sinaloa, 80230, Mexico
Zydus MX006

Guadalajara, Jalisco, 44130, Mexico
Zydus US001

Indianapolis, Indiana, 46202, United States
Zydus US002

San Francisco, California, 94143, United States
Zydus US003

Marion, Ohio, 43302, United States
Zydus US004

Panorama City, California, 91402, United States
Zydus US005

Chandler, Arizona, 85224, United States
Zydus US007

San Antonio, Texas, 78215, United States
Zydus US008

Aurora, Colorado, 80045, United States
Zydus US009

San Antonio, Texas, 78229, United States
Zydus US010

Miami, Florida, 33125, United States
Zydus US011

Morehead City, North Carolina, 28557, United States
Zydus US013

Austin, Texas, 78745, United States
Zydus US014

Philadelphia, Pennsylvania, 19104, United States
Zydus US015

Hershey, Pennsylvania, 17033, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.